Fertility and Sterility
Volume 94, Issue 5 , Pages 1832-1839 , October 2010

Gonadotropin releasing hormone antagonists suppress aromatase and anti-Müllerian hormone expression in human granulosa cells

  • Nurit Winkler, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, the University of Texas Southwestern Medical Center at Dallas, Dallas, Texas
    • ,
  • Orhan Bukulmez, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Florida College of Medicine, Gainesville, Florida
    • ,
  • Daniel B. Hardy, Ph.D.

      Affiliations

    • Departments of Obstetrics and Gynecology & Physiology and Pharmacology, The University of Western Ontario, London, Ontario, Canada
    • ,
  • Bruce R. Carr, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, the University of Texas Southwestern Medical Center at Dallas, Dallas, Texas
    • Corresponding Author InformationReprint requests: Bruce R. Carr, M.D., Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75235-9032 (FAX: 214-648-8066).

Received 9 May 2009 ,Revised 15 September 2009 ,Accepted 16 September 2009.

References 

  1. Fauser BC, Devroey P, Cyen SS, Gosden R, Crowley WF, Baird DT, et al. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod. 1999;14:2681–2686
  2. Droesch K, Muasher S, Brzyski R, Jones G, Simonetti S, Liu H, et al. Value of suppression with a gonadotropin-releasing hormone agonist beforegonadotropin stimulation for in vitro fertilization. Fertil Steril. 1989;51:292–297
  3. Schally AV, Halmos G, Pinski J. Terminology for luteinizing hormone-releasing hormone antagonists. Fertil Steril. 1995;64:226
  4. Pinski J, Lamharzi N, Halmos G, Groot K, Jungwirth A, Vadillo-Buenfil M, et al. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist Cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels. Endocrinology. 1996;37:3430–3436
  5. Halmos G, Schally AV, Pinski J, Vadillo-Buenfil M, Groot K. Down-regulation of pituitary receptors for luteinizing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix. Proc Natl Acad Sci USA. 1996;93:2398–2402
  6. Cetel NS, Rivier J, Vale W, Yen SS. The dynamics of gonadotropin inhibition in women induced by an antagonistic analog of gonadotropin-releasing hormone. J Clin Endocrinol Metab. 1983;57:62–65
  7. Frydman R, Cornel C, de Ziegler D, Taieb J, Spitz IM, Bouchard P. Prevention of premature luteinizing hormone and progesterone rise with a gonadotrophin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation. Fertil Steril. 1991;56:923–927
  8. Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T, et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod. 1994;9:788–791
  9. Leroy I, D'Acremon M, Brailly-Tabard S, Frydman R, de Mouzon J, Bouchard P. A single injection of a gonadotrophin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during LH surge. Fertil Steril. 1994;62:461–467
  10. Olivennes F, Fanchin R, Bouchard P, De Ziegler D, Taieb J, Selva J, et al. The single or dual administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in an in vitro fertilization–embryo transfer program. Fertil Steril. 1994;62:468–476
  11. Felberbaum RE, Diedrich K. Ovarian stimulation for IVF/ICSI with gonadotrophins and GnRH analogues: agonist and antagonist. Hum Reprod. 1999;14;COH:207–21
  12. Gustofson RL, Segars JH, Larsen FW. Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome. Hum Reprod. 2006;11:2830–2837
  13. Bukulmez O, Rehman KS, Langley M, Carr BR, Nackley AC, Doody KM, et al. Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation. Reprod Biomed Online. 2006;13:465–475
  14. Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update. 2006;12:333–340
  15. Roulier R, Chabert-Orsini V, Sitri MC, Barry B, Terriou P. Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment. Reprod Biomed Online. 2003;7:185–189
  16. Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moreau L, et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril. 2000;73:314–320
  17. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K, et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod. 2000;15:526–531
  18. Hsueh AJ, Jones PB. Extrapituitary actions of gonadotrophin-releasing hormone. Endocr Rev. 1981;2:437–461
  19. Hsueh AJ, Erickson GF. Extrapituitary action of gonadotropin-releasing hormone: direct inhibition ovarian steroidogenesis. Science. 1979;204:854–855
  20. Dekel N, Lewysohn O, Ayalon D, Hazum E. Receptor for GnRH are present in rat oocytes. Endocrinology. 1988;123:1205–1207
  21. Fekete M, Bajusz S, Groot K, Csernus VJ, Schally AV. Comparison of different agonists and antagonists of luteinizing hormone-releasing hormone for receptor-binding ability to rat pituitary and human breast cancer membranes. Endocrinology. 1989;124:946–955
  22. Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, et al. High affinity binding and direct antiproliferative effects of LHRH-analogues in cell lines of human ovarian cancer. Acta Endocrinol. 1992;126:93–97
  23. Minaretzis D, Jakubowski M, Mortola JF, Pavlou SN. Gonadotrophin-releasing hormone receptor gene expression in human ovary and granulosa–lutein cells. J Clin Endocrinol Metab. 1995;80:430–434
  24. Minaretzis D, Alper MM, Oskowith SP, Lobel SM, Mortola JF, Pavlou SN. Gonadotrophin-releasing hormone antagonist vs agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa–lutein cells. Am J Obstet Gynecol. 1995;172:1518–1525
  25. Murdoch WJ. Immunolocalization of a GnRH receptor site in murine endometrium that mediates apoptosis. Cell Tissue Res. 1995;282:527–529
  26. Ortmann O, Diedrich K. Pituitary and extrapituitary actions of goandotrophin-releasing hormone and its analogues. Hum Reprod. 1999;14:194–206
  27. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP. Anti-Müllerian hormone and its role in ovarian function. Steroids. 2008;73:473–487
  28. La Marca A, Pati M, Orvieto R, Stabile G. Carducci Artenisio A, Volpe A. Serum anti-müllerian hormone levels in women with secondary amenorrhea. Fertil Steril. 2006;85:1547–1549
  29. van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005;83:979–987
  30. Grossman MP, Nakajima ST, Fallat ME, Siow Y. Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril. 2008;89:1364–1370
  31. Yding Andersen C, Rosendahl M, Byskov AG. Concentration of anti-Müllerian hormone and inhibin-B in relation to steroids and age in follicular fluid from small antral human follicles. J Clin Endocrinol Metab. 2008;93:2344–2349
  32. Dumesic DA, Lesnick TG, Stassart JP, Ball GD, Wong A. Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer. Fertil Steril. 2008;31;[Epub ahead of print]
  33. Mendelson CR, Jiang B, Shelton JM, Richardson JA, Hinshelwood MM. Transcriptional regulation of aromatase in placenta and ovary.J Steroid Biochem Mol Biol. 2005;95:25–33
  34. Mendelson CR, Kamat A. Mechanisms in the regulation of aromatase in developing ovary and placenta. J Steroid Biochem Mol Biol. 2007;106:62–70
  35. Stocco C. Aromatase expression in the ovary: hormonal and molecular regulation. J Clin Endocrinol Metab. 2008;93:3471–3477
  36. Sirianni R, Seely JB, Attia G, Stocco DM, Carr BR, Pezzi V, et al. Liver receptor homologue-1 is expressed in human steroidogenic tissues and activates transcription of genes encoding steroidogenic enzymes. J Endocrinol. 2002;174:R13–R17
  37. Clyne CD, Kovacic A, Speed CJ, Zhou J, Pezzi V, Simpson ER. Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue. Cell Endocrinol. 2004;215:39–44
  38. Halvorson LM. Transcriptional regulation of the LH beta gene by gonadotropin-releasing hormone and the protein kinase C system. Vitam Horm. 2000;60:195–227
  39. Zheng W, Yang J, Jiang Q, He Z, Halvorson LM. Liver receptor homologue-1 regulates gonadotrope function. Mol Endocrinol. 2007;38:207–219
  40. McAllister JM, Mason JI, Byrd W, Trant JM, Waterman MR, Simpson ER. Proliferating human granulosa-lutein cells in long term monolayer culture: expression of aromatase, cholesterol side-chain cleavage, and 3ß-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab. 1990;71:26–33
  41. Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc. 2006;1:581–585
  42. Bukulmez O, Hardy DB, Carr BR, Word RA, Mendelson CR. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinol. 2008;149:1190–1204
  43. Knobil E. The neuroendocrine control of the human menstrual cycle. Recent Prog Horm Res. 1980;36:53–886
  44. Metallinou C, Asimakopoulos B, Schröer A, Nikolettos N. Gonadotropin-releasing hormone in the ovary. Reprod Sci. 2007;14:737–749
  45. Neil J. GnRH and GnRH receptor genes in the human genome. Endocrinol. 2002;143:737–743
  46. Schally AV, rimura A, Baba Y, Nair RM, Matsuo H, Redding TW, et al. Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun. 1971;43:393–9
  47. Cheng CK, Leung PC. Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev. 2005;26:283–306
  48. Kang SK, Choi KC, Yang HS, Leung PC. Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer. Endocr Relat Cancer. 2003;10:169–177
  49. Urbanski HF, White RB, Fernald RD, Kohama SG, Garyfallou VT, Densmore VS. Regional expression of mRNA encoding a second form of gonadotropin-releasing hormone in the macaque brain. Endocrinology. 2000;140:1945–1948
  50. Kakar SS, Musgrove LC, Devor DC, Sellers JC, Neill JD. Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun. 1992;189:289–295
  51. Peng C, Fan NC, Ligier M, Väänänen J, Leung PC. Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology. 1994;135:1740–1746
  52. Havelock JC, Rainey WE, Carr BR. Ovarian granulosa cell lines. Mol Cell Endocrinol. 2004;228:67–78
  53. Parinaud J, Beaur A, Bourreau E, Vieitez G, Pontonnier G. Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells. Fertil Steril. 1988;50:597–602
  54. Lanzone A, Panetta V, Di Simone N, Arno E, Fulghesu AM, Caruso A, et al. Effect of gonadotrophin-releasing hormone and related analogue on human luteal cell function in vitro. Hum Reprod. 1989;4:906–909
  55. Pellicer A, Miro F. Steroidogenesis in vitro of human granulosa-luteal cells pretreated in vivo with gonadotropin-releasing hormone analogs. Fertil Steril. 1990;54:590–596
  56. Miro F, Sampaio MC, Tarin JJ, Pellicer A. Steroidogenesis in vitro of human granulosa-luteal cells pretreated in vivo with two gonadotropin releasing hormone analogs employing different protocols. Gynecol Endocrinol. 1992;6:77–84
  57. Guerrero HE, Stein P, Asch RH, De Fried EP, Tesone M. Effect of a gonadotropin-releasing hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells. Fertil Steril. 1993;59:803–808
  58. Bussenot I, Azoulay C, Barjonet C, Parinaud J. Modulation of the steroidogenesis of cultured human granulosa lutein cells by gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab. 1993;76:1376–1379
  59. Saxena D, Escamilla-Hernandez R, Little-Ihrig L, Zeleznik AJ. Liver receptor homolog-1 and steroidogenic factor-1 have similar actions on rat granulosa cell steroidogenesis. Endocrinology. 2007;148:726–734
  60. Zhao H, Li Z, Cooney AJ, Lan ZJ. Orphan nuclear receptor function in the ovary. Front Biosci. 2007;12:3398–3405
  61. Bukulmez O, Hardy DB, Carr BR, Auchus RJ, Toloubeydokhti T, Word RA, et al. Androstenedione up-regulation of endometrial aromatase expression via local conversion to estrogen: potential relevance to the pathogenesis of endometriosis. Biol Reprod. 2008;79:1074–1083
  62. Pelusi C, Ikeda Y, Zubair M, Parker KL. Impaired follicle development and infertility in female mice lacking steroidogenic factor 1 in ovarian granulosa cells. J Clin Endocrinol Metab. 2008;93:3471–3477
  63. AL Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, et al. Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001;142:4891–4899
  64. Seifer DB, MacLaughlin DT, Penzias AS, Behrman HR, Asmundson L, Donahoe PK, et al. Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid mullerian-inhibiting substance and androgen content. J Clin Endocrinol Metab. 1993;76:711–714
  65. Van Rooij A, Broekmans FJ, Te Velde ER, Fauser BC, Bancsi LF, De Jong FH. Themmen, Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065–3071
  66. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:468–471
  67. Fanchin R, Schonauer LM, Righini C, Frydman N, Frydman R, Taieb J. Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod. 2003;18:328–332
  68. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril. 2004;82:1323–1329
  69. Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod. 2005;20:3178–3183
  70. Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, et al. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles. Fertil Steril. 2008;89:860–867

 N.W. has nothing to disclose. O.B. has nothing to disclose. D.B.H. has nothing to disclose. B.R.C. has nothing to disclose.

PII: S0015-0282(09)03711-X

doi: 10.1016/j.fertnstert.2009.09.032

Fertility and Sterility
Volume 94, Issue 5 , Pages 1832-1839 , October 2010

Article Tools

* Image Usage & Resolution